Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols.

MLA

Redfors, Björn. “Regulatory Bodies and Health Care Systems Should Systematically Evaluate the Safety and Cost-Effectiveness of New Cardiovascular Treatments in Health Care Registries Using Prospectively Designed Protocols.” Scandinavian Cardiovascular Journal : SCJ, vol. 58, no. 1, Dec. 2024, p. 2343383. EBSCOhost, https://doi.org/10.1080/14017431.2024.2343383.

APA

Redfors, B. (2024). Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols. Scandinavian Cardiovascular Journal : SCJ, 58(1), 2343383. https://doi.org/10.1080/14017431.2024.2343383

Chicago

Redfors, Björn. 2024. “Regulatory Bodies and Health Care Systems Should Systematically Evaluate the Safety and Cost-Effectiveness of New Cardiovascular Treatments in Health Care Registries Using Prospectively Designed Protocols.” Scandinavian Cardiovascular Journal : SCJ 58 (1): 2343383. doi:10.1080/14017431.2024.2343383.